2/4/2013

Indian drugmakers support the European Medicines Agency's guideline on health-based exposure restrictions for use in ascertaining the risks of making different treatments, such as cytotoxic drugs, hormones or antibiotics, in the same plant, according to a regional drug manufacturing group.

Related Summaries